Olympiad Research’s Organon & Co OGN Stock Holding History

Olympiad Research’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.03M	Hold	75,358	–	–	1.34%	6
2026 Q2	$1.02M	Buy	+75,358	New	+$901K	2.12%	10

Other funds holding OGN

Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Public Sector Pension Investment Board (PSP Investments) Montreal, Quebec, Canada $45.4B AUM 34.02% 1-Year Est. Return

Private Management Group Irvine, California $3.63B AUM 11.02% 1-Year Est. Return

Olympiad Research's OGN Position: Q3 2026 in Review

Olympiad Research held its Organon & Co (OGN) position steady in Q3 2026 at 75,358 shares worth $1.03M. The position accounts for 1.34% of the portfolio, ranked #6.

Olympiad Research first reported a position in OGN in Q2 2026 and has held it in 2 quarters since. 359 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

Olympiad Research held 75,358 shares of Organon & Co worth $1.03M as of Q3 2026.
Olympiad Research left its Organon & Co share count unchanged in Q3 2026.
Organon & Co made up 1.34% of Olympiad Research's portfolio in Q3 2026, its #6 holding.
Olympiad Research first reported a position in Organon & Co in Q2 2026 and has held it in 2 quarters since.
359 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Olympiad Research's 13F filing for Q3 2026, filed 4 Nov 2026.